Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Marco Borghesi et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Giuseppe Lucarelli, Martha Orsolya Katalin et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 48
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsiesMatteo Ferro, Daniela Terracciano, Giuseppe Lucarelli et al.|World Journal of Urology|2020Cited by 20
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre studyMatteo Ferro, Luigi Schips, Michele Marchioni et al.|Minerva Urology and Nephrology|2021Cited by 13
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional databaseAnnamaria Porreca, Michele Marchioni, Marta Di Nicola et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 9